HUP0003922A3 - Use of thiazolidinediones for the treatment of hyperglycaemia - Google Patents

Use of thiazolidinediones for the treatment of hyperglycaemia

Info

Publication number
HUP0003922A3
HUP0003922A3 HU0003922A HUP0003922A HUP0003922A3 HU P0003922 A3 HUP0003922 A3 HU P0003922A3 HU 0003922 A HU0003922 A HU 0003922A HU P0003922 A HUP0003922 A HU P0003922A HU P0003922 A3 HUP0003922 A3 HU P0003922A3
Authority
HU
Hungary
Prior art keywords
hyperglycaemia
thiazolidinediones
treatment
Prior art date
Application number
HU0003922A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HUP0003922A2 publication Critical patent/HUP0003922A2/hu
Publication of HUP0003922A3 publication Critical patent/HUP0003922A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0003922A 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia HUP0003922A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003064 WO1999018943A1 (fr) 1997-10-13 1998-10-12 Utilisation de thiazolidinediones pour le traitement de l'hyperglycemie

Publications (2)

Publication Number Publication Date
HUP0003922A2 HUP0003922A2 (hu) 2001-10-28
HUP0003922A3 true HUP0003922A3 (en) 2001-12-28

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003922A HUP0003922A3 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Country Status (24)

Country Link
EP (1) EP1023056A1 (fr)
JP (1) JP2001519382A (fr)
KR (1) KR20010024481A (fr)
CN (1) CN1281359A (fr)
AP (1) AP2000001787A0 (fr)
AU (1) AU9547098A (fr)
BG (1) BG104404A (fr)
BR (1) BR9815219A (fr)
CA (1) CA2306086A1 (fr)
CZ (1) CZ20001297A3 (fr)
EA (1) EA002659B1 (fr)
GB (1) GB9721693D0 (fr)
HR (1) HRP20000255A2 (fr)
HU (1) HUP0003922A3 (fr)
ID (1) ID24521A (fr)
IL (1) IL135513A0 (fr)
NO (1) NO20001898L (fr)
NZ (1) NZ503862A (fr)
OA (1) OA11683A (fr)
PL (1) PL339813A1 (fr)
SK (1) SK5312000A3 (fr)
TR (1) TR200000958T2 (fr)
WO (1) WO1999018943A1 (fr)
YU (1) YU28800A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (fr) * 1987-09-04 1998-05-20 Beecham Group Plc Thiazolidinédiones substituées
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
CA2306086A1 (fr) 1999-04-22
CZ20001297A3 (cs) 2001-08-15
OA11683A (en) 2005-01-12
BR9815219A (pt) 2001-01-02
AP2000001787A0 (en) 2000-06-30
PL339813A1 (en) 2001-01-02
KR20010024481A (ko) 2001-03-26
EP1023056A1 (fr) 2000-08-02
EA002659B1 (ru) 2002-08-29
CN1281359A (zh) 2001-01-24
HRP20000255A2 (en) 2001-02-28
BG104404A (bg) 2000-12-29
GB9721693D0 (en) 1997-12-10
IL135513A0 (en) 2001-05-20
ID24521A (id) 2000-07-20
HUP0003922A2 (hu) 2001-10-28
NO20001898L (no) 2000-06-09
NZ503862A (en) 2003-01-31
EA200000419A1 (ru) 2000-10-30
AU9547098A (en) 1999-05-03
SK5312000A3 (en) 2000-09-12
YU28800A (sh) 2003-02-28
JP2001519382A (ja) 2001-10-23
WO1999018943A1 (fr) 1999-04-22
TR200000958T2 (tr) 2000-08-21
NO20001898D0 (no) 2000-04-12

Similar Documents

Publication Publication Date Title
GB2321719B (en) Liquid treatment
AU1542895A (en) Surface treatment
HUP0002030A3 (en) Use of glur5 receptorantagonists for the treatment of pain
AU3124295A (en) Surface treatment techniques
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
GB9511214D0 (en) Surface treatment
GB2304286B (en) Biocidal hard surface treatment
IL130831A0 (en) Imino-aza-anthracylinone derivatives for the treatment of amyloidosis
IL123530A0 (en) Procedure for the surface treatment of petrous materials
AP2000001788A0 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
GB2355006B (en) Materials treatment
IL135513A0 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
GB9416410D0 (en) Effluent treatment
GB9726223D0 (en) The treatment of materials
HK1031098A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
HK1030745A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
GB9717451D0 (en) Apparatus for treatment of surfaces
AUPO458197A0 (en) Synthetic surface treatment apparatus
GB2331514B (en) Effluent treatment
GB9611315D0 (en) Treatment of painted surfaces
AU5203898A (en) Synthetic surface treatment apparatus
GB9605961D0 (en) Surface treatment
GB9615469D0 (en) Surface treatment
GB9402103D0 (en) Surface treatment

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished